These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15918978)

  • 1. [Status and prospect of antibody-directed targeting treatment for hepatocellular carcinoma].
    Yang DH
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):380-1. PubMed ID: 15918978
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor site-directed therapy for hepatocellular carcinoma using monoclonal antibodies against hepatoma-associated antigens.
    Shouval D; Adler R
    Prog Liver Dis; 1993; 11():251-67. PubMed ID: 8272514
    [No Abstract]   [Full Text] [Related]  

  • 3. Accumulation of highly acidic sulfated glycosphingolipids in human hepatocellular carcinoma defined by a series of monoclonal antibodies.
    Hiraiwa N; Fukuda Y; Imura H; Tadano-Aritomi K; Nagai K; Ishizuka I; Kannagi R
    Cancer Res; 1990 May; 50(10):2917-28. PubMed ID: 2159366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Affinity maturation of a single-chain antibody against hepatocellular carcinoma].
    Lu XH; Yang DH; Zhou M; Tang SH
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):192-5. PubMed ID: 16556413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Active immunization: circulating antibodies in experimental hepatoma].
    Más M; Chordi A
    Rev Med Univ Navarra; 1975; 19(1):41-7. PubMed ID: 188089
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibodies as targeting and therapeutic agents: prospects for liver transplantation, hepatitis and hepatocellular carcinoma.
    Luk JM; Wong KF
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):482-8. PubMed ID: 16700883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new murine monoclonal antibody against human hepatoma.
    Stein R; Wang ZF; Sharkey RM; Klein KM; Goldenberg DM
    Hybridoma; 1991 Apr; 10(2):255-67. PubMed ID: 1651901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action of monoclonal antibody against a hepatocellular carcinoma cell line (PLC/PRF/5)].
    Shao RP
    Zhonghua Zhong Liu Za Zhi; 1986 Jul; 8(4):259-61. PubMed ID: 3019621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two mouse hybridomas secreting monoclonal antibodies against human liver carcinoma and their antibody specificity].
    Xie H; Yang ZH; Chen RM; Yao Z; Wang BM; Guo SY; Yan ZF
    Shi Yan Sheng Wu Xue Bao; 1985 Jun; 18(2):263-70. PubMed ID: 2424200
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody-directed therapy for human hepatocellular carcinoma.
    Mohr L; Yeung A; Aloman C; Wittrup D; Wands JR
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S225-31. PubMed ID: 15508088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alpha 1 fetoglobulin and hepatoma].
    Mukojima T; Hattori N
    Gan No Rinsho; 1971 Jun; 17(6):419-23. PubMed ID: 4326804
    [No Abstract]   [Full Text] [Related]  

  • 12. [Construction, expression and characterization of humanized single-chain Fv dimers for hepatocellular carcinoma].
    Bie CQ; Yang DH; Liu L
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):466-7. PubMed ID: 19567031
    [No Abstract]   [Full Text] [Related]  

  • 13. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor imaging and targeting therapy for hepatocellular carcinoma. Preliminary results of experimental and clinical studies.
    Tang ZY; Lui KD; Guo YD; Ma ZC; Yu D; Yu ZY; Boa YM; Lu JZ; Lin ZY; Yu YQ
    Chin Med J (Engl); 1986 Nov; 99(11):855-60. PubMed ID: 3034515
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preparation of functional antibodies targeting tumor endothelia for the treatment of hepatic carcinoma].
    Hu H; Ran YL; Yu L; Zhou Z; Lou JN; Yang ZH
    Ai Zheng; 2007 May; 26(5):453-7. PubMed ID: 17672931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell-associated immunotherapy: a promising strategy for the treatment of hepatocellular carcinoma.
    Ma W; Chen X; Yuan Y
    Immunotherapy; 2017 Jun; 9(7):523-525. PubMed ID: 28595519
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunology of hepatocellular carcinoma.
    Paroli M; Perrone A; Bonavita MS; Barnaba V
    Ital J Gastroenterol; 1991 Nov; 23(8):494-7. PubMed ID: 1661196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitizer conjugation to the carcinoma 19-9 monoclonal antibody.
    Borlinghaus KP; Fitzpatrick DA; Heindel ND; Mattis JA; Mease BA; Schray KJ; Shealy DJ; Walton HL; Woo DV
    Cancer Res; 1987 Aug; 47(15):4071-5. PubMed ID: 3496956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma.
    Sun K; Wang L; Zhang Y
    Cell Mol Immunol; 2006 Jun; 3(3):197-203. PubMed ID: 16893500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of radioiodinated antibody to alpha-fetoprotein in hepatoma transplanted in rats and a case report of alpha-fetoprotein antibody treatment of a hepatoma patient.
    Koji T; Ishii N; Munehisa T; Kusumoto Y; Nakamura S; Tamenishi A; Hara A; Kobayashi K; Tsukada Y; Nishi S; Hirai H
    Cancer Res; 1980 Aug; 40(8 Pt 2):3013-5. PubMed ID: 6156759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.